JP2008519826A5 - - Google Patents

Download PDF

Info

Publication number
JP2008519826A5
JP2008519826A5 JP2007540808A JP2007540808A JP2008519826A5 JP 2008519826 A5 JP2008519826 A5 JP 2008519826A5 JP 2007540808 A JP2007540808 A JP 2007540808A JP 2007540808 A JP2007540808 A JP 2007540808A JP 2008519826 A5 JP2008519826 A5 JP 2008519826A5
Authority
JP
Japan
Prior art keywords
general formula
enantiomers
pharmaceutically acceptable
racemates
mixtures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007540808A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008519826A (ja
JP5020089B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2005/053716 external-priority patent/WO2006051502A2/en
Publication of JP2008519826A publication Critical patent/JP2008519826A/ja
Publication of JP2008519826A5 publication Critical patent/JP2008519826A5/ja
Application granted granted Critical
Publication of JP5020089B2 publication Critical patent/JP5020089B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007540808A 2004-11-11 2005-11-11 心臓血管疾患の治療のためのエンドセリン受容体アンタゴニストとしてのスルファミド類 Expired - Fee Related JP5020089B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EPPCT/EP2004/012774 2004-11-11
EP2004012774 2004-11-11
PCT/IB2005/053716 WO2006051502A2 (en) 2004-11-11 2005-11-11 Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases

Publications (3)

Publication Number Publication Date
JP2008519826A JP2008519826A (ja) 2008-06-12
JP2008519826A5 true JP2008519826A5 (cg-RX-API-DMAC7.html) 2008-12-25
JP5020089B2 JP5020089B2 (ja) 2012-09-05

Family

ID=36177271

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007540808A Expired - Fee Related JP5020089B2 (ja) 2004-11-11 2005-11-11 心臓血管疾患の治療のためのエンドセリン受容体アンタゴニストとしてのスルファミド類

Country Status (21)

Country Link
US (1) US7868012B2 (cg-RX-API-DMAC7.html)
EP (1) EP1833821B1 (cg-RX-API-DMAC7.html)
JP (1) JP5020089B2 (cg-RX-API-DMAC7.html)
KR (1) KR101285463B1 (cg-RX-API-DMAC7.html)
CN (1) CN101056872A (cg-RX-API-DMAC7.html)
AR (1) AR051764A1 (cg-RX-API-DMAC7.html)
AT (1) ATE503752T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005303435A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0517565A (cg-RX-API-DMAC7.html)
CA (1) CA2586106C (cg-RX-API-DMAC7.html)
CY (1) CY1111578T1 (cg-RX-API-DMAC7.html)
DE (1) DE602005027251D1 (cg-RX-API-DMAC7.html)
DK (1) DK1833821T3 (cg-RX-API-DMAC7.html)
ES (1) ES2362103T3 (cg-RX-API-DMAC7.html)
MX (1) MX2007005566A (cg-RX-API-DMAC7.html)
PL (1) PL1833821T3 (cg-RX-API-DMAC7.html)
PT (1) PT1833821E (cg-RX-API-DMAC7.html)
RU (1) RU2007121842A (cg-RX-API-DMAC7.html)
SI (1) SI1833821T1 (cg-RX-API-DMAC7.html)
TW (1) TW200628467A (cg-RX-API-DMAC7.html)
WO (1) WO2006051502A2 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008120093A1 (en) * 2007-04-03 2008-10-09 Pfizer Inc. Sulfonamides and pharmaceutical compositions thereof
MX350011B (es) * 2008-08-13 2017-08-22 Actelion Pharmaceuticals Ltd Composiciones terapeuticas que contienen macitentan.
AR095727A1 (es) 2013-03-27 2015-11-04 Actelion Pharmaceuticals Ltd Preparación de intermediarios de pirimidina
US9899745B2 (en) 2013-09-13 2018-02-20 Raytheon Company Low profile high efficiency multi-band reflector antennas
CN103724281A (zh) * 2013-12-03 2014-04-16 镇江圣安医药有限公司 N-[5-(4-溴苯基)-6-[2-[(5-溴-2-嘧啶基)氧基]乙氧基]-4-嘧啶基]-n′-丙基磺酰胺的新型衍生物及其应用
CN104447572A (zh) * 2014-12-15 2015-03-25 南京艾德凯腾生物医药有限责任公司 一种马西替坦的制备方法
CN111479808B (zh) * 2017-11-21 2023-02-24 无锡智康弘义生物科技有限公司 嘧啶磺酰胺类衍生物、其制备方法及其在医药上的应用
CN108997223B (zh) * 2018-08-09 2020-06-30 浙江先锋科技股份有限公司 5-(4-溴苯基)-4,6-二氯嘧啶的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2086544C1 (ru) 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
TW394761B (en) 1993-06-28 2000-06-21 Hoffmann La Roche Novel Sulfonylamino Pyrimidines
IL111959A (en) 1993-12-17 2000-07-16 Tanabe Seiyaku Co N-(polysubstituted pyrimidin-4-yl) benzenesulfonamide derivatives their preparation and pharmaceutical compositions containing them
TW313568B (cg-RX-API-DMAC7.html) 1994-12-20 1997-08-21 Hoffmann La Roche
US5739333A (en) 1995-05-16 1998-04-14 Tanabe Seiyaku Co., Ltd. Sulfonamide derivative and process for preparing the same
KR100456650B1 (ko) 1995-12-20 2005-06-20 야마노우치세이야쿠 가부시키가이샤 아릴에텐설폰아미드유도체
JPH10226649A (ja) * 1996-12-12 1998-08-25 Tanabe Seiyaku Co Ltd 医薬組成物
EP1693372A1 (en) 2000-12-18 2006-08-23 Actelion Pharmaceuticals Ltd. Novel Sulfamides and their use as endothelin receptor antagonists
NZ540937A (en) 2002-12-02 2008-06-30 Actelion Pharmaceuticals Ltd Pyrimidine-sulfamides and their use as endothelian receptor antagonist

Similar Documents

Publication Publication Date Title
ES2271642T3 (es) Derivados de tiazol como inhibidores de la fosfodieterasa iv.
US7399759B2 (en) 1, 3-benzothiazinone derivatives and use thereof
JP2015164972A5 (cg-RX-API-DMAC7.html)
RU2012144332A (ru) Циклоалкил-замещенное производное имидазола
JP2005538123A5 (cg-RX-API-DMAC7.html)
JP2013121919A (ja) 血漿カリクレイン阻害剤
RU2005111589A (ru) Производные 1-пиридин-4-илмочевины
JP2013515000A (ja) 血漿カリクレインの阻害薬のプロドラッグ
JP4482513B2 (ja) N2−(置換アリールメチル)−3−(置換フェニル)インダゾールおよびこれを含む抗血管形成剤
JP2010514716A5 (cg-RX-API-DMAC7.html)
JP2005539088A5 (cg-RX-API-DMAC7.html)
JP2003508353A5 (cg-RX-API-DMAC7.html)
RU2010109543A (ru) Производные 4-пиримидинсульфамида
JP2010516702A5 (cg-RX-API-DMAC7.html)
CA2399813A1 (en) Indol-3-yl derivatives
JP2007533672A5 (cg-RX-API-DMAC7.html)
CA2370244A1 (en) Piperidine derivatives
RU2006136091A (ru) Применение органических соединений
JP2574585B2 (ja) 再潅流損傷の防止又は制限のための薬剤
JP7688744B2 (ja) 結晶
JP2007506692A5 (cg-RX-API-DMAC7.html)
JP2008524249A5 (cg-RX-API-DMAC7.html)
JP2005528459A5 (cg-RX-API-DMAC7.html)
CA2586106C (en) Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases
JP2009503094A5 (cg-RX-API-DMAC7.html)